Penn Vet | Clinical Trial Detail - A pilot study to evaluate the effectiveness and field safety of SB-009 as a monotherapy for the management of diabetes mellitus in cats
Contact
New Bolton Center Kennett Square, PA
Emergencies & Appointments:
610-444-5800
Directions
Ryan Hospital Philadelphia, PA
Emergencies:
215-746-8911
Appointments:
215-746-8387
Directions

A pilot study to evaluate the effectiveness and field safety of SB-009 as a monotherapy for the management of diabetes mellitus in cats

Jan 12, 2021

Diabetes mellitus is a condition in which the pancreas does not produce enough of a hormone called insulin, which helps the body control blood glucose levels. If not controlled, diabetes can cause symptoms such as increased drinking, increased urination, and weight loss. If blood glucose remains elevated for long periods of time it can cause more serious symptoms and even death. Standard of care treatment currently involves daily insulin injections and changes in diet. The purpose of this study is to evaluate the safety and effectiveness of a one-time gene therapy treatment designed to replace or support insulin treatment for the management of feline diabetes mellitus.

Eligibility:

  • Cats newly diagnosed with diabetes mellitus that have been on treatment for less than 6 months
  • Cats over 2 years of age
  • Cats must be otherwise stable and healthy
  • Owners must be willing and able to complete all paperwork electronically

Benefits:

  • All study-related procedures including the study drug, insulin, physical exams and blood work are covered
  • Up to $500 incentive for time and travel

If you have a cat that may be eligible and you would like to learn more, please contact the Veterinary Clinical Investigations Center at 215-573-0302 or vcic@vet.upenn.edu.